Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reshaping cAMP nanodomains through targeted disruption of compartmentalised phosphodiesterase signalosomes
Authors
Keywords
-
Journal
BIOCHEMICAL SOCIETY TRANSACTIONS
Volume -, Issue -, Pages BST20190252
Publisher
Portland Press Ltd.
Online
2019-09-10
DOI
10.1042/bst20190252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphorylation of PDE4A5 by MAPKAPK2 attenuates fibrin degradation via p75 signalling
- (2019) K F Houslay et al. JOURNAL OF BIOCHEMISTRY
- Targeting B-Raf inhibitor resistant melanoma with novel cell penetrating peptide disrupters of PDE8A – C-Raf
- (2019) Connor M. Blair et al. BMC CANCER
- Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases
- (2019) Faisa Omar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond
- (2019) George S. Baillie et al. NATURE REVIEWS DRUG DISCOVERY
- c-Raf in KRas Mutant Cancers: A Moving Target
- (2018) Frank McCormick CANCER CELL
- Inhibiting Integrin α5 Cytoplasmic Domain Signaling Reduces Atherosclerosis and Promotes Arteriogenesis
- (2018) Madhusudhan Budatha et al. Journal of the American Heart Association
- Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners
- (2016) Kirsty F. Houslay et al. BIOCHEMICAL JOURNAL
- Location, location, location: PDE4D5 function is directed by its unique N-terminal region
- (2016) Lauren Wills et al. CELLULAR SIGNALLING
- RAS isoforms and mutations in cancer at a glance
- (2016) G. Aaron Hobbs et al. JOURNAL OF CELL SCIENCE
- Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling
- (2016) Sanguk Yun et al. NATURE CELL BIOLOGY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- Adenylate cyclase-centred microdomains
- (2014) Dermot M. F. Cooper et al. BIOCHEMICAL JOURNAL
- The cardioprotective role of small heat-shock protein 20: Figure 1
- (2014) Tamara P. Martin et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Advances in targeting cyclic nucleotide phosphodiesterases
- (2014) Donald H. Maurice et al. NATURE REVIEWS DRUG DISCOVERY
- Mice deficient in phosphodiesterase-4A display anxiogenic-like behavior
- (2014) Rolf T. Hansen et al. PSYCHOPHARMACOLOGY
- Targeted disruption of the heat shock protein 20-phosphodiesterase 4D (PDE4D) interaction protects against pathological cardiac remodelling in a mouse model of hypertrophy
- (2014) Tamara P. Martin et al. FEBS Open Bio
- Targeting protein–protein interactions within the cyclic AMP signaling system as a therapeutic strategy for cardiovascular disease
- (2013) Louisa CY Lee et al. Future Medicinal Chemistry
- Phosphodiesterase-8A binds to and regulates Raf-1 kinase
- (2013) K. M. Brown et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The A-kinase-anchoring protein AKAP-Lbc facilitates cardioprotective PKA phosphorylation of Hsp20 on Ser16
- (2012) Helen V. Edwards et al. BIOCHEMICAL JOURNAL
- PKA phosphorylation of the small heat-shock protein Hsp20 enhances its cardioprotective effects
- (2012) Helen V. Edwards et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Specific interactions between Epac1, β-arrestin2 and PDE4D5 regulate β-adrenergic receptor subtype differential effects on cardiac hypertrophic signaling
- (2012) Magali Berthouze-Duquesnes et al. CELLULAR SIGNALLING
- The Future of Peptide-based Drugs
- (2012) David J. Craik et al. Chemical Biology & Drug Design
- The emerging role of HSP20 as a multifunctional protective agent
- (2011) H.V. Edwards et al. CELLULAR SIGNALLING
- Spatial control of cAMP signalling in health and disease
- (2011) Manuela Zaccolo CURRENT OPINION IN PHARMACOLOGY
- Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)–HSP20 complex attenuates the β-agonist induced hypertrophic response in cardiac myocytes
- (2011) Y.Y. Sin et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
- (2011) Sharron H. Francis et al. PHYSIOLOGICAL REVIEWS
- A Complex between FAK, RACK1, and PDE4D5 Controls Spreading Initiation and Cancer Cell Polarity
- (2010) Bryan Serrels et al. CURRENT BIOLOGY
- Cyclic AMP Phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a Vascular Endothelial Cadherin (VE-Cad)-based Signaling Complex and Controls cAMP-mediated Vascular Permeability
- (2010) Sarah N. Rampersad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Roflumilast
- (2010) Leonardo M. Fabbri et al. NATURE REVIEWS DRUG DISCOVERY
- Decreased Expression and Activity of cAMP Phosphodiesterases in Cardiac Hypertrophy and Its Impact on β-Adrenergic cAMP Signals
- (2009) Aniella Abi-Gerges et al. CIRCULATION RESEARCH
- Blockade of Hsp20 Phosphorylation Exacerbates Cardiac Ischemia/Reperfusion Injury by Suppressed Autophagy and Increased Cell Death
- (2009) Jiang Qian et al. CIRCULATION RESEARCH
- Compartmentalized signalling: spatial regulation of cAMP by the action of compartmentalized phosphodiesterases
- (2009) George S. Baillie FEBS Journal
- Signaling from β1- and β2-adrenergic receptors is defined by differential interactions with PDE4
- (2008) Wito Richter et al. EMBO JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started